Results 231 to 240 of about 348,034 (261)
Some of the next articles are maybe not open access.

Immunotherapy of Cancer

1989
When, in the 1960s Burnet’s immunosurveillance hypotheses became common knowledge among clinicians, many of them took it for granted that human tumors carried tumor antigens which allowed the host, theoretically, to recognize and reject his or her own cancer cells.
openaire   +2 more sources

Cancer Immunotherapy

The American Journal of Nursing, 1973
M J, Silverstein, D L, Morton
openaire   +4 more sources

Immunotherapy for colorectal cancer

Current Oncology Reports, 1999
The outlook for patients with colorectal cancer has improved considerably in the past decade with the development and widespread use of 5-fluorouracil (5-FU)-based adjuvant chemotherapy for patients with stage III colon cancer or stages II or III rectal cancer; the introduction of effective new agents such as irinotecan and oxaliplatin; and the ...
openaire   +2 more sources

Immunotherapy of pancreatic cancer

2019
Pancreatic ductal adenocarcinoma (PDAC) is predicted to become the second most common cause of cancer-related death in the United States by 2030. So far surgery remains the only curative option for pancreatic cancer, but fewer than 20% of patients have surgically resectable disease.
Yoshiaki, Sunami, Jörg, Kleeff
openaire   +2 more sources

Cancer Immunotherapy—An Overview

Immunotherapy has had a profound impact on how we treat cancer. Immunotherapy takes advantage of the body's immune system to combat the disease and is considered as one of the pillars of cancer care together with chemotherapy, radiation therapy, and surgery.
Prakash, Kulkarni   +4 more
openaire   +2 more sources

Overcoming hurdles in cancer immunotherapy

Nature Reviews Microbiology, 2021
York Ashley
exaly  

IMMUNOTHERAPY OF CANCER

Medical Journal of Australia, 1971
openaire   +2 more sources

Current treatment and recent progress in gastric cancer

Ca-A Cancer Journal for Clinicians, 2021
Smita Joshi, Brian Badgwell
exaly  

A review of cancer immunotherapy toxicity

Ca-A Cancer Journal for Clinicians, 2020
Lucy Kennedy
exaly  

Home - About - Disclaimer - Privacy